Taking into account the well-established association of PALB2 with BC and its close relationship with BRCA1 and BRCA2, it is legitimate to inquire whether mutations in this gene would enhance the risk for ovarian cancer (OC). This evidence concerns the gene PALB2 and breast cancer.